Citigroup’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$676K Buy
68,715
+9,770
+17% +$92.6K ﹤0.01% 3732
2026
Q1
$505K Buy
58,945
+2,042
+4% +$18.3K ﹤0.01% 3538
2025
Q4
$502K Sell
56,903
-4,039
-7% -$46.7K ﹤0.01% 3567
2025
Q3
$807K Sell
60,942
-10,365
-15% -$130K ﹤0.01% 3300
2025
Q2
$974K Buy
71,307
+54,471
+324% +$733K ﹤0.01% 3210
2025
Q1
$231K Sell
16,836
-257
-2% -$3.75K ﹤0.01% 4119
2024
Q4
$292K Buy
17,093
+8,328
+95% +$144K ﹤0.01% 4165
2024
Q3
$161K Buy
+8,765
New +$155K ﹤0.01% 4492

Other funds holding ARDT

Citigroup's ARDT Position: Q2 2026 in Review

Citigroup increased its Ardent Health (ARDT) stake by 17% in Q2 2026, buying an estimated $92.6K and bringing the position to 68,715 shares worth $676K. The position accounts for ﹤0.01% of the portfolio, ranked #3732.

Citigroup first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $974K in Q2 2025. 138 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Citigroup held 68,715 shares of Ardent Health worth $676K as of Q2 2026.
  • Citigroup bought 9,770 Ardent Health shares in Q2 2026, an estimated $92.6K.
  • Ardent Health made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3732 holding.
  • Citigroup first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • Citigroup's Ardent Health position peaked at $974K in Q2 2025.
  • 138 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.